Product Description
in the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: PaceMate
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description

Countries in Clinic: